Warren Questions Novo Nordisk-Catalent Deal
This is a U.S. news story, published by Yahoo, that relates primarily to Elizabeth Warren news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsElizabeth Warren news
For more Elizabeth Warren news, you can click here:
more Elizabeth Warren newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Novo Nordisk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest contract drug manufacturer Catalent news, Novo news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novo HoldingsReuters
•US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
75% Informative
U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal.
Novo Holdings , the investment firm that has a controlling interest in Novo Nordisk , signed a deal to buy Catalent in February .
Warren urged the Federal Trade Commission to sue to block the deal if the regulator finds it illegal.
VR Score
83
Informative language
89
Neutral language
38
Article tone
formal
Language
English
Language complexity
65
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links